ACI submits tox data to FSA

Compliance CBD novel food

The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]

CBD in food: 12,000 products now pending authorisation as FSA releases final list

The Food Standards Agency has updated the public list of CBD products, adding an additional 6,000 products. This is the complete list of ingestible CBD products currently allowed to remain on the market, which have been linked to a credible novel foods application.    These are the only ingestible CBD products which can be sold […]

EFSA suspends novel food applications due to ‘data gaps and uncertainties’ 

lab tests

The European Food Safety Authority (EFSA) has ‘stopped the clock’ on 19 novel food applications for CBD, pending new data. The EU authority says its scientists cannot currently establish the safety of CBD as a novel food due to data gaps and uncertainties about potential hazards related to CBD intake. The news follows the submission […]

FSA issues final call for ingestible CBD products

26 may FSA issues final call

The Food Standards Agency (FSA) has issued a final call for ingestible CBD products to be added to the public list. The register of consumable CBD products was revealed on 31 March and comprises 3,536 products. Only those on the list have a credible application for authorisation with the FSA and as a result are […]

The CBD list in numbers

the CBD list in numbers

Cannabinoid Insight has monitored the various numbers and statements made since the publication of the CBD list by the Food Standards Agency (FSA) in March. Here is how things stand in April 2022, in the weeks after the list went live. Since 1 January 2021, the FSA has received over 900 novel food applications for CBD […]

UK CBD sector on standby for release of FSA’s list of permitted products

The UK’s consumer health sector is set for its biggest shake-up in more than a decade when the Food Standards Agency (FSA) releases its eagerly-awaited public list of CBD products permitted for sale to consumers. Only products on the list will be able to stay on the market, while those not included will have to […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]